| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |